VXRT Vaxart, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $89.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $9.0K |
| 2022-Q2 | $16.1K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $15.2K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $13.6K | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $49.0K | $0 |
| 2025-Q3 | $66.0K | $0 |
| 2025-Q4 | $24.1K | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $6.5K | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$190.6K13 buy days
Sold$37.8K2 sell days
Net insider flow+$152.7Knet buying · 5 years
Latest trade2026-05-22Watson W. Mark
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Buy | Watson W. Mark | Director | 10,000 | $0.65 | $6.5K | 1 |
| 2025-11-17 | Buy | HERON ELAINE J | Director | 40,000 | $0.40 | $15.9K | 2 |
| 2025-11-17 | Buy | Watson W. Mark | Director | 20,000 | $0.41 | $8.2K | 2 |
| 2025-08-15 | Buy | Finney Kevin | Director | 100,000 | $0.36 | $36.0K | 2 |
| 2025-07-30 | Buy | Finney Kevin | Director | 25,874 | $0.38 | $9.8K | 1 |
| 2025-07-29 | Buy | Watson W. Mark | Director | 10,000 | $0.41 | $4.1K | 1 |
| 2025-07-28 | Buy | Finney Kevin | Director | 20,000 | $0.40 | $8.0K | 1 |
| 2025-07-25 | Buy | Finney Kevin | Director | 20,000 | $0.39 | $7.8K | 1 |
| 2025-07-17 | Buy | Finney Kevin | Director | 794 | $0.38 | $302 | 1 |
| 2025-05-19 | Buy | Lo Steven | President | 100,000 | $0.49 | $49.0K | 1 |
| 2024-06-18 | Buy | Watson W. Mark | Director | 20,000 | $0.68 | $13.6K | 1 |
| 2022-12-28 | Buy | Watson W. Mark | Director | 20,000 | $0.76 | $15.2K | 1 |
| 2022-06-22 | Buy | Ahmad Fuad | CFO | 5,000 | $3.22 | $16.1K | 1 |
| 2022-01-10 | Sell | Yedid Robert A. | Director | 1,500 | $6.01 | $9.0K | 1 |
| 2021-11-30 | Sell | Echerd Margaret | EVP / SVP | 3,602 | $8.00 | $28.8K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Finney Kevin | Director | $61.9K | $0 | 2025-08-15 |
| Lo Steven | President | $49.0K | $0 | 2025-05-19 |
| Watson W. Mark | Director | $47.6K | $0 | 2026-05-22 |
| Echerd Margaret | EVP / SVP | $0 | $28.8K | 2021-11-30 |
| Ahmad Fuad | CFO | $16.1K | $0 | 2022-06-22 |
| HERON ELAINE J | Director | $15.9K | $0 | 2025-11-17 |
| Yedid Robert A. | Director | $0 | $9.0K | 2022-01-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2019-09-26 → 2019-11-07 | 3 | $2.6M | 59 | -21.0% (-16.4% raw) | -5.0% (+7.6% raw) | +455.2% (+436.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.